Alzheimer's disease is widely held to be associated with oxidative stress due, in part, to the membrane action of amyloid ␤-peptide (A␤) aggregates. In this study, the involvement of oxidative stress on A␤-induced energy metabolism dysfunction was evaluated on PC12 cells. It was shown that A␤ peptides (A␤25-35 and A␤1-40) induce a concentration-dependent accumulation of reactive oxygen species (ROS), decrease the cellular redox activity, and lead to the depletion of ATP levels. The observed inhibition by A␤ of mitochondrial function and of glycolysis is blocked by the antioxidants vitamin E, idebenone, and GSH ethyl ester. Taken together, these data suggest that exposure of PC12 cells to A␤ results in an impairment of energy metabolism, leading to a deficit in ATP levels and to the compromise of cellular viability. Furthermore, the generation of ROS seems to be a crucial event responsible for the energetic metabolic dysfunction induced by A␤.
INTRODUCTION
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the gradual impairment of memory function and accumulation of neurofibrillary tangles and neuritic plaques in brain regions subserving cognitive functions (Selkoe, 1993) . A consistent feature of AD patients, detected by brain imaging methods, is the impairment of glucose metabolism in brain regions that exhibit neuritic plaques and that may occur early in the disease process prior to neuronal degeneration (Kalaria & Harik, 1989; Sims, 1990; Hoyer et al., 1991; Jagust et al., 1991; Kennedy et al., 1995) . High levels of oxidative stress (Smith et al., 1995; Yankner, 1996; Mark et al., 1996) and increased levels of protein oxidation (Smith et al., 1991) and lipid peroxidation (Lovell et al., 1995) occur in vulnerable regions of AD brain, and histological analyses suggest increased protein oxidation and glycation in tanglebearing neurons (Smith et al., 1995) .
Several factors that may contribute to oxidative stress and neurofibrillary degeneration in AD, including age-related decreases in energy availability and mitochondrial function (Bowling & Beal, 1995) , disruption of cellular calcium homeostasis (Mattson et al., 1993) , excitotoxicity (Greenamyre & Young, 1989) , and accumulation of amyloid ␤-peptide (A␤) (Yankner, 1996) , have been described. The amyloid ␤-peptide, the major component of neuritic plaques, is a 40-to 42-amino-acid proteolytic fragment of the amyloid precursor protein (Kang et al., 1987) . Incubation of A␤ in vitro results in a concentration-and time-dependent formation of neurotoxic fibrils (Pike et al., 1993) , similar to those characteristic of amyloid-containing plaques present in the brains of AD patients. The sequence corresponding to amino acids 25-35 of A␤ (A␤25-35) forms fibrils and is neurotoxic by a mechanism similar to that of A␤1-40/42 (Yankner et al., 1990; Pike et al., 1993) . The involvement of oxidative stress in A␤ neurotoxicity has been suggested: A␤ accumulation is associated with protein oxidation (Smith et al., 1991) , lipid peroxidation (Lovell et al., 1995) , and advanced glycation end products (Smith et al., 1994) in AD brain; the aggregation of A␤ in vitro is catalyzed by oxidation and is inhibited by antioxidants (Dyrks et al., 1992) ; A␤ neurotoxicity is attenuated by a number of antioxidants (Behl et al., 1992; Bruce et al., 1996) ; A␤ itself induces reactive oxygen species (ROS) generation (Behl
